TSH receptor autoantibody immunoassay in patients with Graves' disease: Improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis

Autoimmunity Reviews

Volumn 12, Issue 2, 2012, Pages 107-113

  Tozzoli, R ^a   Bagnasco, M ^b   Giavarina, D ^c   Bizzaro, N ^d  

^a S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c SAN BORTOLO HOSPITAL   (Italy)

^d San Antonio Hospital   (Italy)

Author keywords

Graves' disease; Hyperthyroidism; Sensitivity; Specificity; TRAb immunoassay; TSHR antibodies

Indexed keywords

THYROTROPIN RECEPTOR ANTIBODY;

AUTOIMMUNITY; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; GRAVES DISEASE; HUMAN; IMMUNOASSAY; MEDLINE; META ANALYSIS; PUBLICATION; REVIEW; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

AUTOANTIBODIES; GRAVES DISEASE; HUMANS; IMMUNOLOGIC TESTS; ODDS RATIO; RECEPTORS, THYROTROPIN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84870247763     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.07.003     Document Type: Review

References (53)

1. Rees Smith B., Sanders J., Furmaniak J. TSH receptor antibodies. Thyroid 2007, 17:923-938.
2. Matthews D.C., Syed A.A. The role of TSH receptor antibodies in the management of Graves' disease. Eur J Intern Med 2011, 22:213-216.
3. Hamidi S., Chen C.R., McLachlan S.M., Rapoport B. Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in the region of the receptor crystal structure. Thyroid 2011, 21:1013-1020.
4. Zophel K., Roggenbuck D., Schott M. Clinical review about TRAb assay's history. Autoimmun Rev 2010, 9:695-700.
5. Adams D.D., Purves H.D. Abnormal responses in the assay of thyrotropin. Proc Univ Otago Med Sch 1956, 34:11-12.
6. Meek J.C., Jones A.E., Lewis U.I., VanderLaan W.P. Characterization of the long-acting thyroid stimulator of Graves' disease. Proc Natl Acad Sci U S A 1964, 52:342-349.
7. Lytton S.D., Kahaly G.J. Bioassays for TSH-receptor autoantibodies: an update. Autoimmun Rev 2010, 10:116-122.
8. Rees Smith B., Hall R. Thyroid-stimulating immunoglobulins in Graves' disease. Lancet 1974, 2:427-431.
9. Manley S.W., Bourke J.R., Hawker R.W. The thyrotropin-receptor in guinea-pig thyroid homogenate: interaction with the long-acting thyroid stimulator. J Endocrinol 1974, 61:437-445.
10. Iida Y., Konishi J., Kasagi K., Kuma K., Torizuka K. Detection of TSH-binding inhibitor immunoglobulins by using the Triton-solubilized receptor from human thyroid membranes. Endocrinol Jpn 1982, 29:227-231.
11. Davies T.F. Autoantibodies to the human TSH receptor are not species specific. J Clin Endocrinol Metab 1981, 52:426-431.
12. Shewring G., Rees Smith B. An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol (Oxf) 1982, 17:409-414.
13. Gupta M.K. Thyrotropin-receptor antibodies in thyroid diseases: advances in detection techniques and clinical applications. Clin Chim Acta 2000, 293:1-29.
14. Ilicki A., Gamstedt A., Karlsson F.A. Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies. J Clin Endocrinol Metab 1992, 74:1090-1094.
15. Mukuta T., Tamai H., Oshima A., Morita T., Matsubayashi S., Fukata S., et al. Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH-binding inhibitor immunoglobulin. Clin Endocrinol (Oxf) 1994, 40:215-219.
16. Kawai K., Tamai H., Matsubayashi S., Mukuta T., Morita T., Kubo C., et al. A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of antithyroid drugs. Clin Endocrinol 1995, 43:551-556.
17. Takasu N., Oshiro C., Akamine H., Komiya I., Nagata A., Sato Y., et al. Thyroid-stimulating antibody and TSH-binding immunoglobulins in 277 Graves' patients and in 686 normal subjects. J Clin Invest 1997, 20:452-461.
18. Costagliola S., Morgenthaler N.G., Hoermann R., Badenhoop K., Struck J., Freitag D., et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves'disease. J Clin Endocrinol Metab 1999, 84:90-97.
19. Bolton J., Sanders J., Oda Y., Chapman C., Konno R., Furmaniak J., et al. Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA. Clin Chem 1999, 45:2285-2287.
20. Schott M., Feldkamp J., Bathan C., Fritzen R., Scherbaum W.A., Seissler J. Detecting TSH receptor antibodies with the recombinant TBII assay. Technical and clinical evaluation. Horm Metab Res 2000, 32:429-435.
21. Bülow Pedersen I., Knudsen N., Perrild H., Ovesen L., Laurberg P. TSH receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goiter: a comparison of two competitive binding assays. Clin Endocrinol 2001, 55:381-390.
22. Giovanella L., Ceriani L., Garancini S. Evaluation of 2nd generation radioreceptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation anti-thyroperoxidase antibodies (AbTPO). Q J Nucl Med 2001, 45:115-119.
23. Morgenthaler N.G., Nagata A., Katayama S., Bergmann A., Iitaka M. Detection of low titre TBII in patients with Graves' disease using recombinant human TSH receptor. Clin Endocrinol 2002, 57:193-198.
24. 125I-labelled TSH receptor. J Clin Endocrinol Metab 1999, 84:3797-3802.
25. Sanders J., Evans M., Premawardhana D.K.E., Depretaere H., Jeffreys J., Richards T., et al. Human monoclonal thyroid stimulating autoantibody. Lancet 2003, 362:126-128.
26. Rees Smith B., Bolton J., Young S., Collyer A., Weeden A., Bradbury J., et al. A new assay for thyrotropin receptor autoantibodies. Thyroid 2004, 14:830-835.
27. Gassner D., Golla R., Stock W., Yoshimura H.J., Sanders J., Rees Smith B. Development of a new automated assay for thyrotropin receptor autoantibodies on the Elecsys system. Clin Chem 2007, 53:A145. (Suppl.).
28. Tozzoli R., Kodermaz G., Villalta D., Bagnasco M., Pesce G., Bizzaro N. Accuracy of receptor-based methods for the detection of thyrotropin-receptor antibodies: a new automated 3rd generation immunoassay presents higher analytical and clinical sensitivity for the differential diagnosis of hyperthyroidism. Autoimmun Highlights 2010, 1:95-100.
29. Zophel K., Roggenbuck D., Wunderlich G., Schott M. Continuously increasing sensitivity over three generations of TSH receptor autoantibody assays. Horm Metab Res 2010, 42:900-902.
30. Kamijo K. Study on cutoff value setting for differential diagnosis between Graves' disease and painless thyroiditis using the TRAb (Elecsys TRAb) measurement via the fully automated electrochemiluminescence immunoassay system. Endocr J 2010, 57:895-902.
31. Moher D., Liberati A., Tetziaff J., Altman T.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269. PRISMA Group.
32. Kamijo K. TSH receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto's thyroiditis: a comparison of two two-step assays, coated plate ELISA using porcine TSH receptor and coated tube radioassay using recombinant TSH receptor. Endocr J 2003, 50:113-116.
33. Villalta D., Oronesu E., Tozzoli R., Montagna P., Pesce G., Bizzaro N., et al. Analytical and diagnostic accuracy of "second generation" assays for thyrotropin receptor antibodies with radioactive and chemiluminescent tracers. J Clin Pathol 2004, 57:378-382.
34. Cardia M.S., Lima N., Knobel M., Medeiros-Neto G. Evaluation of a coated tube assay for antithyrotropin receptor antibodies in patients with Graves' disease and other thyroid disorders. Thyroid 2004, 14:295-300.
35. Kamijo K., Ishikawa K., Tanaka M. Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. Endocr J 2005, 525-529.
36. Mankai A., Toumi D., Chadli-Chaieb C., Ghedira-Besbes L., Saad F., Ouertani M., et al. Anti-thyroid-stimulating hormone receptor antibodies determined by second-generation assay. Clin Chem Lab Med 2007, 45:26-29.
37. Yoshimura Noh J., Miyazaki N., Ito K., Takeda K., Hiramatsu S., Morita S., et al. Evaluation of a new rapid and fully automated electroluminescence immunoassay for thyrotropin receptor autoantibodies. Thyroid 2008, 18:1157-1164.
38. Liu C., Hermsen D., Domberg J., Graeber C., Hautzel H., Duan Y., et al. Comparison of M22-based ELISA and human TSH receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. Horm Metab Res 2008, 40:479-483.
39. Massart C., Sapin R., Gibassier J., Agin A., d'Herbomez M. Intermethod variability in TSH-receptor antibody measurement: implication for the diagnosis of Graves' disease and for the follow-up of Graves' ophthalmopathy. Clin Chem 2009, 55:183-186.
40. Aleksic A., Aleksic Z., Stojanovic M. TSH receptor antibodies for confirming the diagnosis and prediction of remission duration, in newly diagnosed Graves' disease patients. Hell J Nucl Med 2009, 12:146-150.
41. Schott M., Hermsen D., Broecker-Preuss M., Casati M., Camara Mas J., Eckstein A., et al. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease: an international multicentre trial. Clin Endocrinol (Oxf) 2009, 71:566-573.
42. Bülow Pedersen I., Handberg A., Knudsen N., Heickendorff L., Laurberg P. Assays for thyroid-stimulating hormone receptor antibodies employing different specific ligands and ligand partners may have similar sensitivity and specificity but are not interchangeable. Thyroid 2010, 10:127-133.
43. Syme N.R., Toft A.D., Stoddart M., Beckett G.J. Clinical performance of the Roche Cobas e411 automated assay system for thyrotropin-receptor antibodies for the diagnosis of Graves' disease. Ann Clin Biochem 2011, 48:471-473.
44. Zophel K., Roggenbuck P., von Landenberg P., Wunderlich G., Gruning T., Kotzerke J., et al. TSH receptor antibody (TRAb) assays based on the human monoclonal antibody M22 are more sensitive than bovine TSH based assays. Horm Metab Res 2010, 42:65-69.
45. Zöphel K., Grüning T., Roggenbuck D., Wunderlich G., Kotzerke J. On specificity of 2nd generation TSH receptor autoantibody measurements. Clin Lab 2008, 54:243-249.
46. Tozzoli R., Bizzaro N. The clinical autoimmunologist and the laboratory autoimmunologist: the two sides of the coin. Autoimmun Rev 2012, 10.1016/j.autrev.2012.02.011.
47. Ginsberg J., von Westarp C. Clinical application of assays for thyrotropin-receptor antibodies in Graves' disease. CMAJ 1986, 134:1141-1147.
48. Baloch Z., Carayon P., Conte-Devolx B., Demers L.M., Feldt-Rasmussen U., Henry J.F., et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003, 13:3-126.
49. Abalovich M., Amino N., Barbour L., Cobin R.H., De Groot L.J., Glinoer D., et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guidelines. J Clin Endocrinol Metab 2007, 92:S1-S47.
50. Bahn R.S., Burch H.B., Cooper D.S., Garber J.R., Greenlee M.C., Klein I., et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011, 21:593-646.
51. Dasgupta S., Savage M.W. Evaluation of management of Graves' disease in district general hospital: achievement of consensus guidelines. Int J Clin Pract 2005, 59:1097-1100.
52. Pearce E.N., Hennessey J.V., McDermott M.T. New American Thyroid Association and American Association of Clinical Endocrinologists guidelines for thyrotoxicosis and other forms of hyperthyroidism: significant progress for the clinician and a guide to future research. Thyroid 2011, 21:573-576.
53. Ajjan R.A., Weetman A.P. Techniques to quantify TSH receptor antibodies. Nat Clin Pract Endocrinol Metab 2008, 8:461-468.